Alvotech (ALVO) Operating Income (2021 - 2026)
Alvotech's (ALVO) quarterly Operating Income came in at $9.7 million in Q1 2026, down 88.32% YoY from $82.8 million in Q1 2025, and down 96.85% on a QoQ basis from $307.5 million in Q4 2025.
Alvotech (ALVO) Operating Income (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has 6 years of Operating Income data on file, last reported at $9.7 million in Q1 2026.
- Quarterly Operating Income fell 88.32% year-over-year to $9.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (down 99.99% YoY) and the FY2025 annual result came in at $78.2 million, up 12.3% from the prior year.
- Operating Income retreated to $9.7 million in Q1 2026, from $307.5 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $96.3 billion in Q2 2023 to a low of -$96.3 billion in Q1 2023.
- A 5-year average of -$76.1 million and a median of -$131.3 million in 2022 frame the typical range for Operating Income.
- The widest YoY moves for Operating Income: up 73453.53% in 2023, down 133121.71% in 2023.
- Tracing ALVO's Operating Income over 5 years: stood at -$346.4 million in 2022, then fell by 2.43% to -$354.9 million in 2023, then jumped by 45.95% to -$191.8 million in 2024, then surged by 260.31% to $307.5 million in 2025, then sank by 96.85% to $9.7 million in 2026.
- The last three Operating Income figures came in at $9.7 million (Q1 2026), $307.5 million (Q4 2025), and -$303.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Alvotech | 1.17 Bn | 1.17 Bn | 5.09 Mn | 9.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.67 Mn |
| Dec 31, 2025 | 307.50 Mn |
| Sep 30, 2025 | -303.39 Mn |
| Jun 30, 2025 | -8.75 Mn |
| Mar 31, 2025 | 82.84 Mn |
| Dec 31, 2024 | -191.82 Mn |
| Sep 30, 2024 | 247.99 Mn |
| Jun 30, 2024 | 48.23 Bn |
| Mar 31, 2024 | -48.42 Bn |
| Dec 31, 2023 | -354.86 Mn |
| Aug 31, 2023 | -189.10 Mn |
| Jun 30, 2023 | 96.33 Bn |
| Mar 31, 2023 | -96.27 Bn |
| Dec 31, 2022 | -346.44 Mn |
| Aug 31, 2022 | -203.58 Mn |
| Jun 30, 2022 | -131.32 Mn |
| Mar 31, 2022 | -72.27 Mn |
| Dec 31, 2021 | 14.53 Mn |
| Sep 30, 2021 | -75.58 Mn |